...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >4-Aminoquinoline-Pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies
【24h】

4-Aminoquinoline-Pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies

机译:4-氨基喹啉-嘧啶杂种:合成,抗疟活性,血红素结合和对接研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of novel 4-aminoquinoline-pyrimidine hybrids has been synthesized and evaluated for their antimalarial activity. Several compounds showed promising in vitro antimalarial activity against both CQ-sensitive and CQ-resistant strains with high selectivity index. All the compounds were found to be nontoxic to the mammalian cell lines. Selected compound 7g exhibited significant suppression of parasitemia in the in vivo assay. The heme binding studies were conducted to determine the mode of action of these hybrid molecules. These compounds form a stable 1:1 complex with hematin suggesting that heme may be one of the possible targets of these hybrids. The interaction of these conjugate hybrids was also investigated by the molecular docking studies in the binding site of PfDHFR. The pharmacokinetic property analysis of best active compounds was also studied using ADMET prediction. (C) 2014 Elsevier Masson SAS. All rights reserved.
机译:已经合成了一系列新颖的4-氨基喹啉-嘧啶杂化物并评估了它们的抗疟活性。几种化合物对具有高选择性指数的CQ敏感和CQ耐药菌株均显示出有希望的体外抗疟活性。发现所有化合物对哺乳动物细胞系无毒。所选择的化合物7g在体内测定中显示出对寄生虫病的显着抑制。进行血红素结合研究以确定这些杂合分子的作用方式。这些化合物与血红素形成稳定的1:1络合物,表明血红素可能是这些杂种的可能靶标之一。这些共轭杂种的相互作用也通过分子对接研究在PfDHFR的结合位点进行了研究。还使用ADMET预测研究了最佳活性化合物的药代动力学特性。 (C)2014 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号